These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35032700)

  • 1. Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept.
    Wolitzky-Taylor K; Glasner S; Tanner A; Ghahremani DG; London ED
    Behav Res Ther; 2022 Mar; 150():104032. PubMed ID: 35032700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use.
    Buckner JD; Morris PE; Zvolensky MJ
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):272-278. PubMed ID: 34264732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.
    Buckner JD; Zvolensky MJ; Ecker AH; Schmidt NB; Lewis EM; Paulus DJ; Lopez-Gamundi P; Crapanzano KA; Bakhshaie J
    Behav Res Ther; 2019 Apr; 115():38-45. PubMed ID: 30442329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
    Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
    Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach bias modification for cannabis use disorder: A proof-of-principle study.
    Sherman BJ; Baker NL; Squeglia LM; McRae-Clark AL
    J Subst Abuse Treat; 2018 Apr; 87():16-22. PubMed ID: 29471922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distress intolerance moderation of motivated attention to cannabis and negative stimuli after induced stress among cannabis users: an ERP study.
    Macatee RJ; Okey SA; Albanese BJ; Schmidt NB; Cougle JR
    Addict Biol; 2019 Jul; 24(4):717-729. PubMed ID: 29737034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
    Leadbeater BJ; Ames ME; Linden-Carmichael AN
    Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR; Bukstein OG; Douaihy AB; Clark DB; Chung TA; Daley DC; Wood DS; Brown SJ
    Drug Alcohol Depend; 2010 Nov; 112(1-2):39-45. PubMed ID: 20576364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
    Wu LT; Zhu H; Mannelli P; Swartz MS
    Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy.
    Kay-Lambkin FJ; Baker AL; Lewin TJ; Carr VJ
    Addiction; 2009 Mar; 104(3):378-88. PubMed ID: 19207345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased drinking in adults with co-occurring cannabis and alcohol use disorders in a treatment trial for marijuana dependence: Evidence of a secondary benefit?
    Dunn HK; Litt MD
    Addict Behav; 2019 Dec; 99():106051. PubMed ID: 31487577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in child and adult biopsychosocial characteristics associated with regular cannabis use in individuals with and without cannabis use disorder.
    Foster KT; Arterberry BJ; Zucker RA; Hicks BM
    Drug Alcohol Depend; 2021 Sep; 226():108887. PubMed ID: 34216859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive-behavioral therapies in the management of adolescents with cannabis use disorder (CUD): A systematic review.
    Mauries S; Dufayet G; Lengereau A; Lejoyeux M; Geoffroy PA; Dupong I
    Drug Alcohol Depend; 2024 Jul; 260():111321. PubMed ID: 38759505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis use and cannabis use disorder.
    Connor JP; Stjepanović D; Le Foll B; Hoch E; Budney AJ; Hall WD
    Nat Rev Dis Primers; 2021 Feb; 7(1):16. PubMed ID: 33627670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CANDIS treatment program for cannabis use disorders: findings from a randomized multi-site translational trial.
    Hoch E; Bühringer G; Pixa A; Dittmer K; Henker J; Seifert A; Wittchen HU
    Drug Alcohol Depend; 2014 Jan; 134():185-193. PubMed ID: 24176199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a computerized distress intolerance intervention on electrocortical reactivity to cannabis and threat cues: A randomized controlled trial.
    Macatee RJ; Preston TJ; Afshar K; Schmidt NB; Cougle JR
    Psychol Addict Behav; 2022 Nov; 36(7):920-929. PubMed ID: 35129994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restructuring reward: A pilot study to enhance natural reward response in adults with cannabis use disorder.
    Sherman BJ; Brasher ZE; Baker NL; McRae-Clark AL; Froeliger BE
    Drug Alcohol Depend; 2023 Aug; 249():110830. PubMed ID: 37329729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot trial of a telehealth-delivered behavioral economic intervention promoting cannabis-free activities among adults with cannabis use disorder.
    Coughlin LN; Bonar EE; Wieringa J; Zhang L; Rostker MJ; Augustiniak AN; Goodman GJ; Lin LA
    J Psychiatr Res; 2023 Jul; 163():202-210. PubMed ID: 37224772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental pathways from prenatal marijuana exposure to Cannabis Use Disorder in young adulthood.
    Sonon K; Richardson GA; Cornelius J; Kim KH; Day NL
    Neurotoxicol Teratol; 2016; 58():46-52. PubMed ID: 27208888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.